MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Binder Steven B. | Director | Nov 22 '24 | Option Exercise | 1.47 | 67,536 | 99,278 | 1,142,562 | Nov 25 09:30 PM | | Binder Steven B. | Director | Nov 22 '24 | Sale | 6.89 | 67,536 | 465,323 | 1,075,026 | Nov 25 09:30 PM | | STEVEN B BINDER | Director | Nov 22 '24 | Proposed Sale | 6.89 | 67,536 | 465,397 | | Nov 22 04:08 PM | | Binder Steven B. | Director | Nov 15 '24 | Option Exercise | 1.47 | 67,539 | 99,282 | 1,142,565 | Nov 19 09:30 PM | | Binder Steven B. | Director | Nov 15 '24 | Sale | 6.76 | 67,539 | 456,564 | 1,075,026 | Nov 19 09:30 PM | | STEVEN B BINDER | Officer | Nov 15 '24 | Proposed Sale | 6.76 | 67,539 | 456,793 | | Nov 15 04:01 PM | | Tross Stuart A | Chief People & Workpl Officer | Nov 06 '24 | Sale | 7.34 | 55,000 | 403,700 | 967,191 | Nov 08 09:30 PM | | STUART A TROSS | Officer | Nov 06 '24 | Proposed Sale | 7.34 | 55,000 | 403,700 | | Nov 06 04:04 PM | | Tross Stuart A | Chief People & Workpl Officer | Sep 03 '24 | Sale | 6.26 | 25,000 | 156,500 | 1,022,191 | Sep 04 09:11 PM | | STUART A TROSS | Officer | Sep 03 '24 | Proposed Sale | 6.26 | 25,000 | 156,380 | | Sep 03 04:25 PM | | Tross Stuart A | Chief People & Workpl Officer | Aug 30 '24 | Sale | 6.33 | 80,000 | 506,050 | 1,047,191 | Aug 30 09:00 PM | | STUART A TROSS | Officer | Aug 30 '24 | Proposed Sale | 6.33 | 80,000 | 506,043 | | Aug 30 04:35 PM | | Castagna Michael | Chief Executive Officer | Aug 29 '24 | Sale | 6.30 | 85,106 | 536,168 | 2,294,836 | Aug 29 09:00 PM | | Binder Steven B. | EVP Special Projects | Aug 29 '24 | Sale | 5.94 | 5,055 | 30,027 | 1,075,026 | Aug 29 09:00 PM | | Thomson David | EVP Genl Counsel & Secretary | Aug 29 '24 | Sale | 5.94 | 5,553 | 32,985 | 829,843 | Aug 29 09:00 PM | | Castagna Michael | Officer | Aug 29 '24 | Proposed Sale | 6.30 | 85,106 | 536,071 | | Aug 29 05:23 PM | | DAVID THOMSON | Officer | Aug 29 '24 | Proposed Sale | 5.94 | 5,553 | 32,988 | | Aug 29 04:15 PM | | STEVEN B BINDER | Officer | Aug 29 '24 | Proposed Sale | 5.94 | 5,055 | 30,031 | | Aug 29 04:15 PM | | Binder Steven B. | EVP Special Projects | Jul 16 '24 | Sale | 5.93 | 2,836 | 16,817 | 1,100,860 | Jul 17 07:49 PM | | Thomson David | EVP Genl Counsel & Secretary | Jul 16 '24 | Sale | 5.93 | 3,115 | 18,472 | 857,885 | Jul 17 07:49 PM | | Thomson David | EVP Genl Counsel & Secretary | May 21 '24 | Sale | 4.66 | 23,537 | 109,682 | 873,616 | May 21 09:00 PM | | Binder Steven B. | EVP Special Projects | May 21 '24 | Sale | 4.66 | 25,952 | 120,936 | 1,114,553 | May 21 09:00 PM | | Binder Steven B. | EVP Special Projects | May 13 '24 | Sale | 4.31 | 3,618 | 15,594 | 845,967 | May 14 09:00 PM | | Thomson David | EVP Genl Counsel & Secretary | May 13 '24 | Sale | 4.31 | 3,047 | 13,133 | 783,446 | May 14 09:00 PM | | Castagna Michael | Chief Executive Officer | Dec 14 '23 | Sale | 4.00 | 110,000 | 440,000 | 2,239,147 | Dec 15 09:00 PM | | Castagna Michael | Chief Executive Officer | Dec 15 '23 | Sale | 4.00 | 90,482 | 361,928 | 2,148,665 | Dec 15 09:00 PM |
|
